Prenetics Global (PRE) Competitors $8.09 +0.79 (+10.82%) Closing price 04:00 PM EasternExtended Trading$8.80 +0.72 (+8.84%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRE vs. CTKB, QSI, AEHR, QTRX, FEIM, MASS, RPID, SEER, KEQU, and NAUTShould you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Cytek Biosciences (CTKB), Quantum-Si (QSI), Aehr Test Systems (AEHR), Quanterix (QTRX), Frequency Electronics (FEIM), 908 Devices (MASS), Rapid Micro Biosystems (RPID), Seer (SEER), Kewaunee Scientific (KEQU), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry. Prenetics Global vs. Cytek Biosciences Quantum-Si Aehr Test Systems Quanterix Frequency Electronics 908 Devices Rapid Micro Biosystems Seer Kewaunee Scientific Nautilus Biotechnology Cytek Biosciences (NASDAQ:CTKB) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends. Do analysts prefer CTKB or PRE? Cytek Biosciences currently has a consensus price target of $5.25, indicating a potential upside of 111.69%. Prenetics Global has a consensus price target of $9.00, indicating a potential upside of 11.25%. Given Cytek Biosciences' higher probable upside, equities analysts plainly believe Cytek Biosciences is more favorable than Prenetics Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytek Biosciences 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer CTKB or PRE? In the previous week, Cytek Biosciences had 2 more articles in the media than Prenetics Global. MarketBeat recorded 3 mentions for Cytek Biosciences and 1 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 1.11 beat Cytek Biosciences' score of 0.94 indicating that Prenetics Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytek Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Prenetics Global 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, CTKB or PRE? Cytek Biosciences has higher revenue and earnings than Prenetics Global. Cytek Biosciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytek Biosciences$197.05M1.59-$12.15M-$0.09-27.56Prenetics Global$30.62M3.22-$62.72M-$3.99-2.03 Is CTKB or PRE more profitable? Cytek Biosciences has a net margin of -5.05% compared to Prenetics Global's net margin of -191.73%. Cytek Biosciences' return on equity of -2.58% beat Prenetics Global's return on equity.Company Net Margins Return on Equity Return on Assets Cytek Biosciences-5.05% -2.58% -2.05% Prenetics Global -191.73%-16.45%-13.34% Do institutionals and insiders believe in CTKB or PRE? 69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 9.6% of Cytek Biosciences shares are held by insiders. Comparatively, 7.8% of Prenetics Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, CTKB or PRE? Cytek Biosciences has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Does the MarketBeat Community prefer CTKB or PRE? Cytek Biosciences received 15 more outperform votes than Prenetics Global when rated by MarketBeat users. However, 87.50% of users gave Prenetics Global an outperform vote while only 44.00% of users gave Cytek Biosciences an outperform vote. CompanyUnderperformOutperformCytek BiosciencesOutperform Votes2244.00% Underperform Votes2856.00% Prenetics GlobalOutperform Votes787.50% Underperform Votes112.50% SummaryCytek Biosciences beats Prenetics Global on 13 of the 18 factors compared between the two stocks. Get Prenetics Global News Delivered to You Automatically Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRE vs. The Competition Export to ExcelMetricPrenetics GlobalAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$98.74M$4.30B$5.35B$8.38BDividend YieldN/A0.57%5.22%4.10%P/E Ratio-2.0326.5826.8419.71Price / Sales3.223.74391.39116.98Price / CashN/A36.2338.2534.62Price / Book0.471.536.794.50Net Income-$62.72M-$84.30M$3.23B$248.18M7 Day Performance39.48%2.97%4.07%1.14%1 Month Performance88.14%6.67%12.52%15.20%1 Year Performance37.82%-24.24%16.83%6.56% Prenetics Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PREPrenetics Global2.0578 of 5 stars$8.09+10.8%$9.00+11.2%+20.3%$98.74M$30.62M-2.031Positive NewsHigh Trading VolumeCTKBCytek Biosciences2.1482 of 5 stars$2.69+0.7%$5.25+95.2%-55.4%$338.18M$197.05M-33.62500News CoverageQSIQuantum-Si2.6488 of 5 stars$1.41-4.7%$3.48+146.5%-5.1%$271.05M$3.44M-2.20150Earnings ReportAnalyst ForecastAnalyst RevisionGap UpAEHRAehr Test Systems3.904 of 5 stars$9.04-2.7%$25.00+176.5%-23.0%$269.13M$61.48M12.0590News CoveragePositive NewsQTRXQuanterix1.8217 of 5 stars$4.87+1.7%$15.60+220.3%-71.0%$189.10M$133.92M-4.59460Positive NewsGap UpFEIMFrequency Electronics2.5455 of 5 stars$18.02-0.7%N/A+87.5%$174.38M$65.40M21.98200Positive NewsMASS908 Devices2.9551 of 5 stars$4.77+4.1%$5.33+11.8%-27.9%$171.06M$63.99M-2.6960Analyst RevisionGap UpRPIDRapid Micro Biosystems1.0759 of 5 stars$3.31+3.1%$8.00+141.7%+284.3%$140.70M$29.65M-2.96200Gap DownSEERSeer1.8429 of 5 stars$2.07flat$3.00+44.9%+0.5%$123.75M$15.06M-1.59160News CoverageKEQUKewaunee Scientific1.824 of 5 stars$36.90-1.1%N/A-12.4%$105.33M$220.03M5.85890Positive NewsGap UpNAUTNautilus Biotechnology2.3989 of 5 stars$0.80-2.9%$2.42+202.1%-71.1%$103.95MN/A-1.43130 Related Companies and Tools Related Companies CTKB Alternatives QSI Alternatives AEHR Alternatives QTRX Alternatives FEIM Alternatives MASS Alternatives RPID Alternatives SEER Alternatives KEQU Alternatives NAUT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRE) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRE Stock Free PRE Stock Alerts